BREXIT HEALTH CHECK

The vote on the relocation of the EMA to Amsterdam is the start of a Brexit process that will have a direct impact on the healthcare sector. Are you prepared and ready to plan and adjust for this change?

With the United Kingdom expected to leave the European Union in March 2019, the pressure will continue to increase for the pharmaceutical industry to clarify its position on a number of important commercial issues that will affect a broad range of stakeholders. With patient care at the forefront of everyone’s concerns, your business needs to be able to communicate its priorities to protect its interests and reputation throughout the transition process.

Your senior team needs to have access to the right intelligence throughout the relocation process to be able to develop and communicate its strategy effectively. For more information on how FTI Consulting can help you amidst these challenges click here.

Also, check out our FTI Consulting’s latest Brexit brochure.

Share This Post

Popular

Related by categories

Related by tags

Comments

*

No comments yet.